NATERA INC (NTRA)
US6323071042 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to NTRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 102.96. This target is 10.85% above the current price.
NTRA was analyzed by 23 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NTRA.
In the previous month the buy percentage consensus was at a similar level.
NTRA was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-15 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-04-05 | Bernstein | Upgrade | Market Perform -> Outperform |
| 2024-03-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-02-20 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2024-01-30 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-01-30 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-17 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-12-29 | BTIG | Maintains | Buy -> Buy |
| 2023-12-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-12-14 | Guggenheim | Initiate | Buy |
| 2023-12-13 | Wolfe Research | Initiate | Outperform |
| 2023-12-12 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-11-13 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2023-11-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-09 | UBS | Maintains | Buy -> Buy |
| 2023-10-20 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-10-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-09-28 | Bernstein | Initiate | Market Perform |
| 2023-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-04 | Credit Suisse | Reiterate | Outperform -> Outperform |
| 2023-07-24 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-07-21 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-05-30 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-05-10 | Baird | Maintains | Outperform |
| 2023-05-10 | Goldman Sachs | Maintains | Buy |
| 2023-05-10 | Credit Suisse | Maintains | Outperform |